Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06006741
What this trial is testing

Universal CAR-T Cells Targeting Multiple Myeloma

Who this might be right for
Multiple Myeloma in Remission
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Active Not RecruitingNCT05168423
What this trial is testing

CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

Who this might be right for
Glioblastoma
University of Pennsylvania 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04637503
What this trial is testing

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Who this might be right for
Neuroblastoma
Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)UnknownNCT03152435
What this trial is testing

EGFR CART Cells for Patients With Metastatic Colorectal Cancer

Who this might be right for
EGFR-positive Colorectal Cancer
Shenzhen Second People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04627740
What this trial is testing

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Who this might be right for
Solid Tumors
Xinqiao Hospital of Chongqing 5
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Early research (Phase 1)Study completedNCT04394650
What this trial is testing

CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Juno Therapeutics, a Subsidiary of Celgene 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT05396885
What this trial is testing

Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)

Who this might be right for
Multiple Myeloma
Kite, A Gilead Company 136
Early research (Phase 1)Study completedNCT02765243
What this trial is testing

Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma

Who this might be right for
NeuroblastomaEffects of Immunotherapy
Zhujiang Hospital 12
Very early researchNot Yet RecruitingNCT07234721
What this trial is testing

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 9
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Not applicableStudy completedNCT05390671
What this trial is testing

CAR-T Cell Therapy in Patients With Hematological Malignancies

Who this might be right for
CART Therapy
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 260
Testing effectiveness (Phase 2)UnknownNCT01935843
What this trial is testing

Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors

Who this might be right for
Advanced HER-2 Positive Solid TumorsChemotherapy RefactoryHER-2 Antibody Inhibitor Therapy Refactory
Chinese PLA General Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06971380
What this trial is testing

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Who this might be right for
Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis
Polina Stepensky 180
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Very early researchUnknownNCT03497819
What this trial is testing

Autologous CARTmeso/19 Against Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University 10